|
HY-N2587-5mg
|
MedChemexpress LLC
|
Irigenin [CAS 548-76-5]
|
|
Cancer-programmed cell death
|
|
|
HY-N2587-1mL
|
MedChemexpress LLC
|
Irigenin [CAS 548-76-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16568-100mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride trihydrate) [CAS 136572-09-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16568-200mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride trihydrate) [CAS 136572-09-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16568-50mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride trihydrate) [CAS 136572-09-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16568-500mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride trihydrate) [CAS 136572-09-3]
|
|
Cancer-programmed cell death
|
|
|
HY-16568-1mL
|
MedChemexpress LLC
|
Irinotecan (hydrochloride trihydrate) [CAS 136572-09-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16562A-100mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride) [CAS 100286-90-6]
|
|
Cancer-programmed cell death
|
|
|
HY-16562A-200mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride) [CAS 100286-90-6]
|
|
Cancer-programmed cell death
|
|
|
HY-16562A-50mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride) [CAS 100286-90-6]
|
|
Cancer-programmed cell death
|
|
|
HY-16562A-500mg
|
MedChemexpress LLC
|
Irinotecan (hydrochloride) [CAS 100286-90-6]
|
|
Cancer-programmed cell death
|
|
|
HY-16562A-1mL
|
MedChemexpress LLC
|
Irinotecan (hydrochloride) [CAS 100286-90-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16562-100mg
|
MedChemexpress LLC
|
Irinotecan [CAS 97682-44-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16562-200mg
|
MedChemexpress LLC
|
Irinotecan [CAS 97682-44-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16562-50mg
|
MedChemexpress LLC
|
Irinotecan [CAS 97682-44-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16562-500mg
|
MedChemexpress LLC
|
Irinotecan [CAS 97682-44-5]
|
|
Cancer-programmed cell death
|
|
|
HY-16562-1mL
|
MedChemexpress LLC
|
Irinotecan [CAS 97682-44-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-16562S1-1mg
|
MedChemexpress LLC
|
Irinotecan-d10 (hydrochloride) [CAS 718612-62-5]
|
|
Cancer-programmed cell death
|
|
|
HY-N0268-1mg
|
MedChemexpress LLC
|
Irisflorentin [CAS 41743-73-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0268-10mg
|
MedChemexpress LLC
|
Irisflorentin [CAS 41743-73-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0268-20mg
|
MedChemexpress LLC
|
Irisflorentin [CAS 41743-73-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0268-5mg
|
MedChemexpress LLC
|
Irisflorentin [CAS 41743-73-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0268-1mL
|
MedChemexpress LLC
|
Irisflorentin [CAS 41743-73-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P72534A-10ug
|
MedChemexpress LLC
|
Irisin, Human (HEK293, His)
|
|
|
|
|
HY-P72534A-100ug
|
MedChemexpress LLC
|
Irisin, Human (HEK293, His)
|
|
|
|
